Esapa, B.; Jiang, J.; Cheung, A.; Chenoweth, A.; Thurston, D.E.; Karagiannis, S.N.
Target Antigen Attributes and Their Contributions to Clinically Approved Antibody-Drug Conjugates (ADCs) in Haematopoietic and Solid Cancers. Cancers 2023, 15, 1845.
https://doi.org/10.3390/cancers15061845
AMA Style
Esapa B, Jiang J, Cheung A, Chenoweth A, Thurston DE, Karagiannis SN.
Target Antigen Attributes and Their Contributions to Clinically Approved Antibody-Drug Conjugates (ADCs) in Haematopoietic and Solid Cancers. Cancers. 2023; 15(6):1845.
https://doi.org/10.3390/cancers15061845
Chicago/Turabian Style
Esapa, Benjamina, Jiexuan Jiang, Anthony Cheung, Alicia Chenoweth, David E. Thurston, and Sophia N. Karagiannis.
2023. "Target Antigen Attributes and Their Contributions to Clinically Approved Antibody-Drug Conjugates (ADCs) in Haematopoietic and Solid Cancers" Cancers 15, no. 6: 1845.
https://doi.org/10.3390/cancers15061845
APA Style
Esapa, B., Jiang, J., Cheung, A., Chenoweth, A., Thurston, D. E., & Karagiannis, S. N.
(2023). Target Antigen Attributes and Their Contributions to Clinically Approved Antibody-Drug Conjugates (ADCs) in Haematopoietic and Solid Cancers. Cancers, 15(6), 1845.
https://doi.org/10.3390/cancers15061845